SpringerLink
Log in

The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

The presence of viruses in the thyroid has been shown, but whether they are implicated in thyroid diseases or are only spectators is under investigation. The most important candidate viruses for autoimmune thyroid disorders (AITD) are hepatitis C virus (HCV) and human parvovirus B19 (or Erythrovirus B19 or EVB19). Retrospective and prospective case–control studies conducted on pathology slides showed (by PCR, in situ hybridization or immunohistochemistry) EVB19 was present in thyroid tissues of patients with autoimmune thyroiditis (AT), Graves’ disease and thyroid cancer. Though AITD can be associated with acute EVB19 infection, it is not clear whether EVB19 could have a pathogenetic role in autoimmune thyroid diseases pathophysiology. Many studies have shown that frequently, patients with HCV chronic infection (CHC) show elevated serum anti-thyroperoxidase (TPOAb) and/or anti-thyroglobulin autoantibodies levels, ultrasonographic signs of chronic AT, and subclinical hypothyroidism. In patients with HCV-associated mixed cryoglobulinemia (MC + HCV), AITD were more prevalent with respect to controls, and also vs HCV patients without cryoglobulinemia. Papillary thyroid cancer was more prevalent in MC + HCV or CHC patients than in controls, especially in patients with AT. Recently it has been shown an elevated incidence of new cases of AT and thyroid dysfunction in MC patients. These results suggest an attentive monitoring of thyroid function and nodules in HCV patients with risk factors (female gender, a borderline high initial thyrotropin, TPOAb positivity, a hypoechoic and small thyroid) for the development of thyroid disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.

    Article  CAS  PubMed  Google Scholar 

  2. Benvenga S, Antonelli A, Vita R. Thyroid nodules and thyroid autoimmunity in the context of environmental pollution. Rev Endocr Metab Disord. 2015;16:319–40.

    Article  CAS  PubMed  Google Scholar 

  3. Morohoshi K, Takahashi Y, Mori K. Viral infection and innate pattern recognition receptors in induction of Hashimoto’s thyroiditis. Discov Med. 2011;12:505–11.

    PubMed  Google Scholar 

  4. Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6:5.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Parsa AA, Bhangoo A. HIV and thyroid dysfunction. Rev Endocr Metab Disord. 2013;14:127–31.

    Article  CAS  PubMed  Google Scholar 

  6. Ungnapatanin N, Subauste JS, Henderson HM, Koch CA. Endocrine aspects in patients infected with the human immunodeficiency virus. J Miss State Med Assoc. 2012;53:347–8.

    PubMed  Google Scholar 

  7. Stamatiou D, Derdas SP, Symvoulakis EK, Sakorafas GH, Zoras O, Spandidos DA. Investigation of BK virus, Epstein-Barr virus and human papillomavirus sequences in postoperative thyroid gland specimens. Int J Biol Markers. 2015;30:e104–10.

    Article  PubMed  Google Scholar 

  8. Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: a review. Acta Virol. 2014;58:199–213.

    Article  CAS  PubMed  Google Scholar 

  9. Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol. 2016;23:5–12.

    Article  CAS  PubMed  Google Scholar 

  10. Adamson LA, Fowler LJ, Ewald AS, Clare-Salzler MJ, Hobbs JA. Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues. J Med Virol. 2014;86:1614–20.

    Article  CAS  PubMed  Google Scholar 

  11. Vejlgaard TB, Nielsen OB. Subacute thyroiditis in parvovirus B19 infection. Ugeskr Laeger. 1994;156:6039–40.

    CAS  PubMed  Google Scholar 

  12. Munakata Y, Kodera T, Saito T, Sasaki T. Rheumatoid arthritis, type 1 diabetes, and graves’ disease after acute parvovirus B19 infection. Lancet. 2005;366:780.

    Article  PubMed  Google Scholar 

  13. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, et al. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto’s thyroiditis. J Infect. 2007;55:e29–31.

    Article  PubMed  Google Scholar 

  14. Seishima M, Shibuya Y, Suzuki S. Hyperthyroidism associated with human parvovirus B19 infection. Clin Exp Dermatol. 2009;34:e439–40.

    Article  CAS  PubMed  Google Scholar 

  15. Lehmann HW, Lutterbüse N, Plentz A, Akkurt I, Albers N, Hauffa BP, et al. Association of parvovirus B19 infection and Hashimoto’s thyroiditis in children. Viral Immunol. 2008;21:379–83.

    Article  CAS  PubMed  Google Scholar 

  16. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer. 2008;98:611–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Adamson LA, Fowler LJ, Clare-Salzler MJ, Hobbs JA. Parvovirus B19 infection in Hashimoto’s thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid. 2011;21:411–7.

    Article  PubMed  Google Scholar 

  18. Page C, Hoffmann TW, Benzerdjeb N, Duverlie G, Sevestre H, Desailloud R. Detection of erythrovirus B19 in thyroidectomy specimens from graves’ disease patients: a case-control study. J Med Virol. 2013;85:1414–9.

    Article  CAS  PubMed  Google Scholar 

  19. Page C, Hoffmann TW, Benzerdjeb N, Desailloud R, Sevestre H, Duverlie G. Immunohistochemical- and PCR-based assay for the reproducible, routine detection of erythrovirus B19 in thyroid tissues. J Med Virol. 2015;87:1054–9.

    Article  CAS  PubMed  Google Scholar 

  20. Wang L, Zhang WP, Yao L, Zhang W, Zhu J, Zhang WC, et al. PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis. Hum Pathol. 2015;46:1913–21.

    Article  CAS  PubMed  Google Scholar 

  21. Page C, Duverlie G, Sevestre H, Desailloud R. Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses. J Med Virol. 2015;87:162–9.

    Article  CAS  PubMed  Google Scholar 

  22. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436–41.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology. 2006;44:15–22.

    Article  PubMed  Google Scholar 

  24. Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP, et al. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J Gastroenterol. 2007;13:6518–28.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis. 2007;16:65–73.

    PubMed  Google Scholar 

  26. Pastore F, Martocchia A, Stefanelli M, Prunas P, Giordano S, Toussan L, et al. Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment. World J Hepatol. 2016;8:83–91.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med. 1998;158:1445–8.

    Article  CAS  PubMed  Google Scholar 

  28. Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol. 1995;132:587–93.

    Article  CAS  PubMed  Google Scholar 

  29. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004;117:10–3.

    Article  CAS  PubMed  Google Scholar 

  30. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology. 1993;18:253–7.

    Article  CAS  PubMed  Google Scholar 

  31. Metcalfe RA, Ball G, Kudesia G, Weetman AP. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid. 1997;7:421–4.

    Article  CAS  PubMed  Google Scholar 

  32. Boadas J, Rodríguez-Espinosa J, Enríquez J, Miralles F, Martínez-Cerezo FJ, González P, et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol. 1995;22:611–5.

    Article  CAS  PubMed  Google Scholar 

  33. Martino E, Macchia E, Aghini-Lombardi F, Antonelli A, Lenziardi M, Concetti R, et al. Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)?. Clin Endocrinol. 1986;24:627–33.

    Article  CAS  Google Scholar 

  34. Indolfi G, Stagi S, Bartolini E, Salti R, de Martino M, Azzari C, et al. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol. 2008;68:117–21.

    Article  Google Scholar 

  35. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol. 1994;89:399–403.

    CAS  PubMed  Google Scholar 

  36. Carella C, Amato G, Biondi B, Rotondi M, Morisco F, Tuccillo C, et al. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res. 1995;44:110–4.

    Article  CAS  PubMed  Google Scholar 

  37. Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med. 1996;101:482–7.

    Article  CAS  PubMed  Google Scholar 

  38. Marazuela M, García-Buey L, González-Fernández B, García-Monzón C, Arranz A, Borque MJ, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol. 1996;44:635–42.

    Article  CAS  Google Scholar 

  39. Carella C, Mazziotti G, Morisco F, Rotondi M, Cioffi M, Tuccillo C, et al. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of develo** hypothyroidism. Eur J Endocrinol. 2002;146:743–9.

    Article  CAS  PubMed  Google Scholar 

  40. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid. 2006;16:563–72.

    Article  PubMed  Google Scholar 

  41. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. J Am Med Assoc. 2007;297:2010–7.

    Article  CAS  Google Scholar 

  42. Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol. 2008;26(1 Suppl 48):S39–47.

    CAS  PubMed  Google Scholar 

  43. Goldman M, Lambert P, Tasiaux N, Vereerstraeten P, Sabot JP, Thoua Y, et al. Thyroid-stimulating immunoglobulins in mixed (type II) cryoglobulinemia associated with thyrotoxicosis. Arthritis Rheum. 1987;30:1318–9.

    Article  CAS  PubMed  Google Scholar 

  44. Castellano Higuera A, Gonzáles Reimers E, Alarcó Hernández B, Santolaria Fernández F, Rodríguez GM. Hypothyroidism, hemolytic anemia and cryoglobulinemia in a patient with hepatitis C virus infection: efficacy of treatment with alpha-interferon. An Med Interna. 2003;20:391–2.

    CAS  PubMed  Google Scholar 

  45. Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Longombardo G, et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM. 2004;97:499–506.

    Article  CAS  PubMed  Google Scholar 

  46. Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA. 1999;281:1588.

    Article  CAS  PubMed  Google Scholar 

  47. Montella M, Crispo A, Pezzullo L, Izzo F, Fabbrocini G, Ronga D, et al. Is hepatitis C virus infection associated with thyroid cancer? A case-control study. Int J Cancer. 2000;87:611–2.

    Article  CAS  PubMed  Google Scholar 

  48. Montella M, Crispo A, de Bellis G, Izzo F, Frigeri F, Ronga D, et al. HCV and cancer: a case-control study in a high-endemic area. Liver. 2001;21:335–41.

    Article  CAS  PubMed  Google Scholar 

  49. Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol. 2002;20:693–6.

    CAS  PubMed  Google Scholar 

  50. Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, et al. Hashimoto’s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer. 2011;18:429–37.

    Article  CAS  PubMed  Google Scholar 

  51. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Barani L, et al. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid. 2007;17:447–51.

    Article  CAS  PubMed  Google Scholar 

  52. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis. 2007;39:S13–21.

    Article  PubMed  Google Scholar 

  53. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469–77.

    Article  PubMed  Google Scholar 

  54. Mihm S, Schweyer S, Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol. 2003;70:562–70.

    Article  CAS  PubMed  Google Scholar 

  55. Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev. 2008;8:8–23.

    Article  Google Scholar 

  56. Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13:272–80.

    Article  CAS  PubMed  Google Scholar 

  57. Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, et al. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists. Endocr Relat Cancer. 2009;16:1299–311.

    Article  CAS  PubMed  Google Scholar 

  58. Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C, Metelli MR, et al. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in graves’ and normal thyrocytes. J Clin Endocrinol Metab. 2010;95:E413–20.

    Article  CAS  PubMed  Google Scholar 

  59. Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol. 2009;27:22–7.

  60. Gowans EJ. Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis. 2000;20:85–102.

    Article  CAS  PubMed  Google Scholar 

  61. Bartolomé J, Rodríguez-Iñigo E, Quadros P, Vidal S, Pascual-Miguelañez I, Rodríguez-Montes JA, et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol. 2008;80:1588–94.

    Article  PubMed  Google Scholar 

  62. Antonelli A, Fazzi P, Fallahi P, Ferrari SM, Ferrannini E. Prevalence of hypothyroidism and graves disease in sarcoidosis. Chest. 2006;130:526–32.

    Article  PubMed  Google Scholar 

  63. Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism. 2010;59:896–900.

    Article  CAS  PubMed  Google Scholar 

  64. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Carpi A, et al. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism. 2008;57:1270–7.

    Article  CAS  PubMed  Google Scholar 

  65. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Sebastiani M, et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine. 2008;42:137–43.

    Article  CAS  PubMed  Google Scholar 

  66. Antonelli A, Ferri C, Ferrari SM, De Marco S, Di Domenicantonio A, Centanni M, et al. Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. J Interf Cytokine Res. 2010;30:835–42.

    Article  CAS  Google Scholar 

  67. Antonelli A, Ferri C, Ferrari SM, Di Domenicantonio A, Ferrari P, Pupilli C, et al. The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. Clin Exp Rheumatol. 2011;29:S17–22.

    PubMed  Google Scholar 

  68. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev. 2007;7:114–20.

    Article  CAS  PubMed  Google Scholar 

  69. Antonelli A, Fallahi P, Ferrari SM, Pupilli C, d’Annunzio G, Lorini R, et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study. Diabet Med. 2008;25:1349–53.

    CAS  PubMed  Google Scholar 

  70. Fallahi P, Ferrari SM, Ruffilli I, Elia G, Giuggioli D, Colaci M, et al. Incidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-up. Autoimmun Rev 2016; doi: 10.1016/j.autrev.2016.03.012. [Epub ahead of print]

  71. Zignego AL, Gragnani L, Piluso A, Sebastiani M, Giuggioli D, Fallahi P, et al. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol. 2015;11:15–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Pisa, Via Savi, 10, I-56126, Pisa, Italy

    Poupak Fallahi, Silvia Martina Ferrari & Alessandro Antonelli

  2. Department of Clinical & Experimental Medicine, University of Messina, Messina, Italy

    Roberto Vita & Salvatore Benvenga

  3. Master Program of Childhood, Adolescence and Women’s Endocrine Health, University of Messina, Messina, Italy

    Salvatore Benvenga

  4. Interdepartmental Program of Molecular & Clinical Endocrinology, and Women’s Endocrine Health, University Hospital, Policlinico G. Martino, 98125, Messina, Italy

    Salvatore Benvenga

Authors
  1. Poupak Fallahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Martina Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Vita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salvatore Benvenga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessandro Antonelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Antonelli.

Ethics declarations

Funding

The authors have nothing to declare.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fallahi, P., Ferrari, S.M., Vita, R. et al. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders. Rev Endocr Metab Disord 17, 529–535 (2016). https://doi.org/10.1007/s11154-016-9361-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-016-9361-4

Keywords

Search

Navigation